obesity therapy (Yamanouchi)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Nameobesity therapy (Yamanouchi)
Drug Alias Nameneuropeptide Y1 antagonist (Yamanouchi)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 1 antagonists
TargetsNeuropeptide Y receptor type 1
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYamanouchi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYamanouchi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A